SCHEMBL23753561

SCHEMBL23753561

[CH2]C12CC(C1)C2NC(=O)COc1ccc(Cl)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ATF4 P18848 19/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22656753 0.80 ATF4 (0.61) ATF4
SCHEMBL22656503 0.80 ATF4 (0.61) ATF4
SCHEMBL16082976 0.79 ATF4 (0.78) ATF4
SCHEMBL20973081 0.79 ATF4 (0.53) ATF4
SCHEMBL21390314 0.79 ATF4 (0.55) ATF4
SCHEMBL22362323 0.77 ATF4 (0.71) ATF4
SCHEMBL22362367 0.77 ATF4 (0.71) ATF4
SCHEMBL21384299 0.77 ATF4 (0.68) ATF4
SCHEMBL21384520 0.76 ATF4 (0.67) ATF4
SCHEMBL19134205 0.76 ATF4 (0.73) ATF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253528-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-08-19 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253528-A1 CHEMICAL COMPOUNDS ATF4, EIF2AK4, ATF1 ATF4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback